Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Thorough Aide - 2Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- 3Incredible Travel Objections for Craftsmanship Darlings to Visit
- 4NAFFIC, AWARE claim first China-EU DPP for textiles
- 54 Home Rec center Hardware Decisions for Little Spaces
- 6 Tire Brands Reasonable for Seniors
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- 6 Objections for an Ocean side Wedding
- Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video)
- Opening Potential: Self-awareness and Long lasting Learning
- Posts falsely claim Netanyahu video fabricated to cover up his death
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- 5 Chiefs That Changed Our Opinion on Film
